Richard Belli Workshop

7/22/2019 Richard Belli Workshop

1/62

CAIRNS 2013ICAK INTERNATIONAL CONFERENCE

19 21 April 2013Cairns Convention Centre, QLD

Australia

Pre Conference Workshopwith Dr Richard Belli

Neurological Applications of AK


2/62

"

ICAK International Conference 2013, Australia

Neurological applications of AKRichard Belli, DC, DACNB, FABNN

()*+,-,./01- 233-/014,56 ,7 233-/)8

9/5)6/,-,.: ;+)0,57)+)50) ,3

?1/+56 2*6@+1-/1

A/0>1+8 B)--/ CD?DE CD2D?D(DBDE FD2DBD(D(D

!"#$ &'($ )* +,

G 7)H )I0)34,56E 1-- 104J/4)6 ,7 @>) ?(KE

+)0)/J/5.E 3+,0)66/5.E 158 /5@).+145. /57,+L14,5E

*-4L1@)-: M586 )I3+)66/,5 /5 0,5@+104,5 ,7 1 L*60-)DN

?,-,+ 2@-16 ,7 ;>:6/,-,.:E 2D C)63,3,*-,6E KD K/-O)+15.)E P)1+

B,,= Q)8/01- ;*O-/6>)+6E R),+. S>/)L) T)+-1.

-./*012 340/ !".405 1/6

71/'12 7'$82. !.$9/:

2-- L*60-) @)645. *-4L1@)-: @)6@6 @>) 0)5@+1-/5@).+14J) 6@1@) ,7 @>) T)5@+1- >,+5

C)@)+L/5)8 O: 6*L @,@1- )U)0@ ,7 6:51340 104J/@:O,@> )I0/@1@,+: 158 /5>/O/@,+:


3/62

#


!"#$ &'()* +,--,( .)/#0)123 4#$55'(6/,(

75)'( 7)8$9 :;

)*+ ,-./0 /1 2*+ 3402-453+02+- 64- .55 7.84-

9*:1/454;/3.5 6+-: ?/@3


4/62

$


!"#$$ &'()*$ +,"-.-/0, !12$(

!12$ +3()*+), -+.,+/0 /**/1+,2* +/-+ 32+4 1) 5,/67).0218

!12$ ++3 9.:/1+ -+.,+/0 /**/1+,2* +/-+ 32+4 5,/67).0+) ;.;.;.@ .1 /**/1+,2* +/-+

!"#$$ &'()*$ +,"-.-/0, !12$( 40,567

!12$ +3 80)50# (59#5$6 A/**/1+,2*B +/-:18 72C/7@ ,/*,=2+-5,2;.,27@ -;.77/, */77-D 8.;;. ;)+), 1/=,)1- 212:.+/- ;=-*7/

*)1+,.*:)1 E2. +4/ -/,E);/*4.12-; )? +4/ 8.;;. 7))5

!12$ ++3 :9/$,5 (59#5$6 50 ;9


5/62

%


!"#$%&%'( %* +,- .%/012

()*++ ,-./* 0+10/*2 314560 7/* 4/065*-8 9/16*/8 -*++2+0: ;+0 ,+9)-1/*+9+46/*0

7*/, 6)+ -1?8+ ./316

@/065*-8 ->-46-+4+1> /1 9+*+=+88-*316+A*-8+ -B+*+160

+,- !"#$%&%'( .%/012

C1.5*2 *+05860 31 15,+*/50 -86+*--46 6/ D+E/* *+D+E -B+*+160 6)-6

-*30+ 7*/, 1/939+46/*0

F+9/1>-*2 +B+960 /7 1/939+4-46-58-


6/62

&


!"# %&'()*+&)

)*+,-+. /01234 2+356-7 .05+-.37089436-7 -, 2:*23491 ;07 /0+*56-7 -, -8*707< .-+61* =-072> -+

,-+?3+/ +-5@07< -, 2:* 324372-A-55080234 =-072 ?:04*

10.94237*-914B 8*+,-+.07< 2:* ,-44-?07+/- 7;:-7 80/0),*2)0,3

=-*1 )*


13/62

"#


!"#$%&' )"**$ +#%,-,. +#%,-,./01 +#."0#"20/#$

3"$4"#5,#6 78,#&* )/05 9"0:"$

!"62*&." !"#$%&' )"**$ ;,& 2/*484;+; 3;5;4*/:+;/:9*+;/

G4567384*> ;/6*48*3;2,+H/*2 3*/ 6;5/* 89/+;06/;2+474C+


14/62

"$


!"#$%"$&%'"( *"+ ,'%-'"$(

()*+,- ./01 *+230+340/+5 ,03 6307 53+5*863 2/9/14-,8/+ :7;

3)0/14.863 ?/09/+35 @?70/*1 ?/09/+35 =+A,99,8/+

!"#$%"$&%'"( *"+ !".*--*/'"

()*+,- ./01 *+230+340/+5 ,03 6307 53+5*863 2/*+A,99,2/07 931*,2/05 54.? ,5;

B0/52,C-,+1*+5 D34E/20*3+35 FGHEI =DHJ @FG, =DH%

012"*3 4'%+ 5678(


15/62

"%


!"#$% '()* +,-

,).$/"0.#1 2%3$4$50% 2%6$.#(0" 7)8(

()*+,-./* 01 ,2).3-4-./3-4 566/3 -)* 427/3 02*18/923 +):+0+;2) 7:/) ./


16/62

"&


!"#"$%&'( *"+,-".

/0#12"#"$%&'( 345+602.+'5 7 8%2609$%":

;$%"$ !'$$5 %# +,' !/ =2+7=.2, /,21 67 BCD /+1 EFD -.0/ 8(##*

$%"/&3 8/.#3/$ #


28/62

#(


!"#$%$& ($#)*"+,-. +.&

/$0%-&$1$.$%+,2$ 345$+5$

)*

+,-% ./0-1 +,-(

+,-( /0-23 +,-4

+,-$ +0/

CRP

6- 7%4.1 #)$ 777 +.& 8"4+" 9$""5 7+:; #-


29/62

#)


!"#$%&'()*+ -./0*1 2#3(4(5"# 6&7*8#

)*+ ,-. /*0, 12+, 3242567.8 090,./ 890:;436


30/62

#*


!"#$% '()(*(+

,(#"- .(/"012345#67

8%9$%-("70+-#1 +4#7( %(#" +-("%/3


31/62

$+


!"#$%&'()* , -"%%.

/0)"" 1$'2(3". (4 /)"&'3"5'

,6%&'")&% .$7)&.765&'$. 6506869(5 ()** +, -*,./,0()12 34 /,5.)3)36 73)*.1,/.* 8.9,/3

:56%&'")&% 8.9,/3 ;6'0($' 7*)&362, ?@A ): . 6/478 4G :7+ -4/;-.* 37-*,) 12.1 2.H,8/4I,-;43: 14 H)/17.**B .** -4/;-.* 3,7/43:

/0" =?')& /0&%&362 -()92&% @(


32/62

$"


!"# %!&'( )*+,-.#/ &"#0-123 '+.4325+6 +7 8"# &+*8#9: -6 &+68*2/8:

!"# ;#51432* /8#0 )*+,-.#/

(#6/+*> '+.4325+6 !"*+4=" 8"# !"23204/

!"# ?413#- +7 8"# %!&'( 2*# '2@+* )*+.415+6


33/62

$#


!"#$%%$&'" $") *+,-.'-/$"

012+$)$&'" '3 .+,-.'-/$" ./+'42/ ./1 5,"4+1"6"1 -$./7$, 8,

6")'9$%6"1 :; < )6'=,21"$>1 $") 6.> $?&@$&'" 8, /62/9, 6")4?6891

-+'6"#$%%$.'+, ?,.'A6"1>


34/62

$$


!"#$%&'() +() ,-')& ./&0&1$% 2()3%&0

4(#50&3"6 789':1 !";(0;:1:"'

()*+,-./,+ 012/,02*),-10 *)3*4*56) 7*-361-28/,9*:,+ 2,;./)

()*+,-./,+ 012/,02*),-10 *)3*4*56) -3,- +&%$0$'&':90: ?@,26*)-0 6) -3. 3.,:

A(05"'&)8 =&':)&0 ,8: 4(;:1:"'9 ()

7&%%:9 B$9)5>'9 C&$'

)*?@,)-@6/5@,+ ,@5=*-8 .02.@*,++8 *) ,) ,/., /.A.//.: -6 ,0

-3. A/6)-,+ .8. ?.+:0

B22,/.)-+8 /.2.,-.: +,-./,+ .8. 96=.9.)- *)@/.,0.0@6/5@,+ ,@5=*-8 .)61>3 -6 @3,++.)>. A6/ ,:.C1,-.

96:1+,56) A/69 -3. DEFGH

I,-./,+ .8. 96=.9.)- :*0/12-0 )6/9,+ *)3*4*56) ,):A,@*+*-,56) 2,;./) 6A -3. >,*- 260*56)


35/62

$%


"# $% &'( )($ %* +(,- .%/'$0 1/22 3%45,2/6(

7,/$ 8/049:$(- ;< #,$(4,2 =%?(5('$

()*+,-. /01,/23,405 25621,7*8 7)* 8259/* 8*7 0: )*,6-02578 7),7 5**6 70 ;* 7+*,7*6 70 1/*,+ (< 70 ,// 0: 7)*

)*,6 =>? -02578 ,56 50+@,/23* 9,27 628+A-7*6 ;.

/,7*+,/ *.* @0B*@*57

.


36/62

$&


!"#$ &' $"( )*+#,&-#. )#/(+01

) *+,-.+/0123 24 &0"&2&340 #' $"( +('5.$ 46-(7+(#'(- -('7(0-&08 &9'&.#$(+#. 74+37#. #73:&$*

+3-2 -56 723-286*099:.; .61?@AB

C56 );


37/62

$'


!"#$%&'$( *+,&-#.,$( /01&2&3.0 !$4+#0

)*+ ,-./-0+1233456 5+782345 9-5047-. :.*:;:/-5< 4;-?+ )@( 4.1 3-A+5 ;-16

+>/+./+./+.-5< ;+3-A )@(

5&%-("6 &-7&($8+#$( 9--+# 2.'" +:8+07.# &01&2&3.0$0' (.;+# 2.'" . =+ ?++' 81+ !"#$%&'$( 5"78+%@

H.85+4


38/62

$(


!"# %& '"( )#*+,%-+. /0"%1%230

)+4(*0 5.%0%6+..# /,73*8+089

)*+,-.* /0* 123,456,7 1,8*39 5. ,..:+5,/*6 /:;-9+:3/*? ),.,7 @,9@75, A0,7,4-. B21:/0,7,4-. )3,59./*4 9-+7*5

:(,%&7"(*( ;62


39/62

$)


!"# %&'() ')* +,-.)./(0 1,)02.)

3,//'&4 .5 6.&/'7 8#90#)*():

;.&20'7 +02


40/62

$*


!"# %&'( )* %+),-+)./

%-+-*/,0-1"#23 )4 5-16+#

)*+ ,-./01 .--2 3-2-. 4561+5/ -7 8095/: 4561+5/2.0625/ /-1;20.;5/: /5?@A B.+/ 605,011= 04, ;


41/62

%+


!"#$%&' )* +',-'#.'/ 0123 )-

4-#56 78'$ +'9,5'6,:

()*+,-.,/ .012-34,5* 36), 72.78-3,+-880 ()*+,-.,/ .9,-5): ()*+,-.,/ ;866/ 2+,.. *8- =-+7*6.75,. ?,*+,-.,/ -+1 .97): 72.78-3,+-880 @,-) 36 *6)3+-8-3,+-8 .7/, (2.78-3,+-8 20+-17/-8 2-A,+)

4-#56.8'$ +'9,5'6,: ;)68/2/,- )I-)0,.2, ?6,/4*-)2*4 ,


46/62

%&


!"##$%&"' )"*+,-&$.

)*+,-./,+ 012 34 5,6*+*-,-.7 *89*6,-.7 7.:;.8-,+ 9?8 @?//.6- A*-B 7.:;.8-,+ CD3 ?/ ;,8*E=+,>?8

3B?8

@?//.6- A*-B CD3 -? *;;=8. @ D -B,- 5,6*+*-,-.7 H3C 5,6*+*-,-.7 *89*6,-.7 ?8. ?5 -B. 5?++?A*8:

I?8,9 @D 34 *89*6,-.7 B?/;?8. *8J?+J.;.8- @?//.6- K< /=KK*8: ?/ CD3 -? *8J?+J.9 @D

H,86/.,7 @D 34 *89*6,-.7 9


47/62

%'


!"# %#&'()*+, -.&/#0 1+& 23), 4+56 2)67'36&

)*+,-./+ -+0 1*23*1./+ /4 1/,5./+ -+0 6/./+ 725*+.+8 9:* :*-0 -+0 ;/0< 9/ =*2.3-> ?/+92/>>5+8 9:* ;/05A5+8 9:* :*-0 0B25+8 1/,9B2-> 6/=*6*+9,

8+'#6/& 95/" 2)67'36+* %#&'()*+, :5&3,;#,& 4+.

8,#/ 95/" -##056/30&

C*3D 1-5+ E-3D 1-5+ FB9/+/653 0-+3* 5,,B*, G,,B*, H59: 3//205+-./+

%#&'()*+, ?>>+,+/)&


48/62

%(


!"# %&'() *#+,-&.(/ 01+2#'3+ 4(5# &6 78 !"/##97'67)#)2+

) *+,-*.+,/0 1+213,4 /**/,/561 ) 7+25,/0 *,37+113, )28 / 9+7./2-19 :3, 9353, 365*65

:)2#;/(,7) 78 2"# *#+,-&.(/ 01+2#' !(# 3) 4&.,6.# ?/#(+

;.+ 60/, 2670+- ),+/1 3: 5.+ >,/-2 15+9 ,+=760/, :3,9/=32 )00 :627=32/0 /,+/1 3: 5.+ 7+,+>+0069 ?/,-361 2670+- 3: 5.+ 5./0/961 @60=*0+ /,+/1 3: 5.+ 7+,+>,/0 73,5+A

!"# =7+2#/37/ :)+&.( 3+ 97)+35#/#5 2"#

*#+,-&.(/ 97/2#@


49/62

%)


!"#$"# &' #() *)+,-"./0 12+#)3 4&)+ #& !5"./0

6"+5.)+ /78 #() 1$97/. :&08 #& 1)0*)

;(0)) )?)+

()* +*,-./01213/045 5*6*7 89:;< ()* +*,-./01310=35*6*7 89>; 3,-


51/62

&+


!"# %#&'()*+, -.&/#0 1& 23/" + 43/3,

+56 -#5&3,. -.&/#0

)*+,*+ -.*/0-1 02 +3. 4)5 6/. +3. 70+0/ -.*/0-1 02+3. 08*96/ 70+0/ -*89.: 807,9.; ?1 @@@A @4A 4@BA

C3:83 D/:E. +3. .;+/6 08*96/ 7*189.1

)*+,*+ -.*/0-1 02 +3. 4F5 6/. +3. 6-+./:0/ 30/-8.991 02 +3. 1,:-69 80/D G/6H 76I./A C3:83 D/:E.1

1J.9.+69 7*189.1

!"# %#&'()*3&715+* !,+8/9 :"18" ;30#&


52/62

&"


!" $ %&'"() (* +)$,-./0 .1& 2&"3456$) %/".&7 -" 8'& (*

.1& 9&),(5" %/".&7:" ;(". ('& $'E H&6$3('"1-=" (*

;5"B6& +)(5=" I-.1 A$B1 8.1&)

E1+B93 27< +B5+7-93 59721 /2127:+ 624 /+ ;:21 -;>721- 8396 5*+ ,+-./0123

-4-5+6 23+


53/62


"#$%&'()* +,$-#. /012&2%30 )04 5)62(2-)%30

7)8#*0$ )*# 7*#426-)&(#

*+,- ./0,.,-1 /2 3/456/-78 9+7-:,4 72, .7;,79585176/- 7-; 5-+5?56/- 37@,2-4

17A, 3879, 1/ .75-175- 7- =325:+1 3/456/- 7-;

?787-9, 5- 2,876/-4+53 1/ ,721+B4 :2705176/-78 C,8;

/012&2%30 )04 5)62(2-)%30 7)8#*0$ )*# -1# 9#$'(- 3:

;#42)( )04


54/62

&$


!"#$%&'() +&,,()-

!"#$%&'() +-#.", /# 0(#/'- 01('&(."2 3/.4

5(6&(' 5'" 8"#$69

)*+ 1"#$%&'() #-#.", &'$,(."'- ,:2&'(."# .:6"(62 ;&67$:6 :; '()9" 9):&


55/62

&%


!"##$%&"' )"*+,-&$.

If the normal facilitation and inhibition patterns of thechallenged systems do not take place, therapy

localization (TL) is done to identify areas of the nervoussystem that may be involved

Once an area of dysfunction is localized, pinch andrub modalities can be utilized to determine the

appropriate treatment modalities

If the area that TLs responds to rubbing, then injuryrecall technique (IRT)is utilized

If the area responds to pinching, thenmanipulationis utilized

If neither rub nor pinch normalizes the aberrantpattern, rehabilitation exercises are utilized

!"##$%&'/ 0$.&12,"%$#$1$,,+# 3""4

56.72'%&"'

)*+ ,+-./0123 -4-5+6 0.178+- 79:;362.;9 :3;6 ;5*+3 -+9-;346;


56/62

&&


)*+ ,+-./0 1+23450627.8/0 9:/;9 ,+-./9+2 68


57/62

&'


!"# %&'(()*+) ,)-.-

*+, -. /0.-12 34011/56/7 82 409-56 :4/ ;03?. >5 05>8@/3: .?34 0. :4/ /A0B-5/CD. E56/C 057 :?C5 :4/ 4/07 .-7/ :>

.-7/ >C ?; 057 7>F5

G/.: .?;C0.;-50:?. G/.: 60-: -54-8-5 057 =03-1-:05 ;0H/C5.

I= :4/ ;08@/3: >= =>3?. =0C /5>?640F02 :40: :4/ /2/. 7> 5>: 3>59/C6/J :4/ :/.:. 0C/ B>C/

.;/3-E3 :> C>:0501 =>C3/. 057 :4/ ./B-3-C3?10C 30501.

I= :4/ >8@/3: -. 31>./ /5>?64 :> 3>59/C6/ :4/ /2/.J :4/ B>5-. B>C/ 1-5/0C 057 :/.:. B>C/ >= :4/ ?:C-31/ 057 .033?1/

!)-/01('2 345'/6* 75)284-)-

*/.5/ 82409-56 :4/ ;017 :4/-C :4?B8. >?: =C>5:

;103/7 :>6/:4/C F-:4 0CB. /A:/57/7K

L:0C9/:4/B :> >5/ .-7/ F4-1/ B>9-56 :4/ 4/07 :> :4/

>;;>.-:/ .-7/J M//;-56 :4/ /2/. EA/7 >5 :4/:4?B8.

G4-. B>9/B/5: -. 7>5/ -5 8>:4 7-C/35.J >C 803M057 =>C:4J =>C 08>?: >5/ B-5?:/J >C ?5


58/62

"#


Neurological applications of AppliedKinesiologyflow chart

Richard Belli, DC, DACNB, FABNN

Tonic Labyrinthine and Neck Reflexes

$% &'()%* (+&),)+% ,'-% .*/0 /%0 ,*&, (*1,+-/2)& 3/4+- 12/5)1'2/- 1+%,-/2/,*-/2 ,+ .*/0 ,'-%6)& %+-3/2278/1)2),/,*0 )% ,7(*& $9 $$9 : $$$

o $8 %+-3/2 8/1)2),/,)+% 0+*& %+, +11'- )% /22 ,.-** ,7(*& 1.*1; ,.* .7(+,./2/3)1 (),'),/-7 *%0+1-)%*/ /& )%0)1/,*0! $8 %+%* +8 ,.* />+5* 8/1)2),/,* 1.*1; =', BCD&

$8 F$G@$ BC ?@ 8/1)2),/,*& ,-*/, E),. $C? +- -'> /& )%0)1/,*0o $8 %+-3/2 8/1)2),/,)+% 0+*& %+, +11'- )% ,7(* $ +%27 ), )%0)1/,*& ,+%)1 %*1; -*82*< 07&8'%1,)+%

! B.*1; &*=3*%,/2 07&8'%1,)+% +8 1*-5)1/2 &()%* B+--*1, E),. H-)=)% : )%&*-,)+% ,*1.%)A'* +- 3/%)('2/,)+%

o $8 %+-3/2 8/1)2),/,)+% 0+*& %+, +11'- )% ,7(* $$ +%27 (*-8+-3 F*, I+)%, ,*1.%)A'* ,+ /-*/ +8 (/)%o $8 %+-3/2 8/1)2),/,)+% 0+*& %+, +11'- )% ,7(* $$$ +%27 (*-8+-3 /',+=*%)1 8/1)2),/,)+% J3'&12* &()%02*K

! L',+=*%)1 8/1)2),/,)+% 8/1)2),/,*& (*-8+-3 MFN ,*1.%)A'*! $8 /',+=*%)1 8/1)2),/,)+% 0+*& %+, 8/1)2),/,* (*-8+-3 $C? ,+ /-*/& +8 (/&, )%4'-)*&

Reciprocal inhibition

$%0)1/,*0 >7 1+%,-/2/,*-/2 '((*- /%0 2+E*- >+07 82*),)+% E.*% ,*&,*0 &)3'2,/%*+'&27 JA'/0-)1*(&/%0 +((+&),* (*1612/5)1'2/-K

B+%,-/1, 2+E*- >+07 82*),)+%

(/,,*-% )% ,7(*& $9 $$9 /%0 $$$

N-/)%9 >-/)% &,*3 QCI /-*/9 &()%/2 1+-0 QCI /-*/&! $8 -*1)(-+1/2 )%.)>),)+% )& &,)22 %+, %+-3/2 1.*1; ,.* 8+22+E)%=

$%&'2)% 3*,/>+2)&36(/%1-*/&9 RI6*%0+1-)%* /7 3'2,)(2* .*/0 (+)%, ?@

Non-canalized system (usually correct only one of the following)

CNS ATP production pathwayso L%/*-+>)1 (/,.E/7&

! N-/)% BC ?@ 8/1)2),/,*& &'(-/&()%/,'& J(+&,*-)+- 2/,*-/2 B6TK $8 )33'%* ?@ 8/1)2),/,*& 1+%&)0*- >/1,*-)/9 5)-'&9 8'%='&

o B+--*1, E),. >)2/,*-/2 3/


59/62

"U

ICAK International Conference 2013, Australiao HK ?-*/, )33'%* BCD& E),. $C? +- -'> /& )%0)1/,*0

! ?.7-+)0 BC )%0)1/,)%= XFR J.*/57 3*,/2 3*,/>+2)&3K ?-*/, 5)&1*-/2 BC ,./, />+2)&.*& ,.7-+)0 BC ?@

! @'%= BC )%0)1/,)%= 8/,,7 /1)0 3*,/>+2)&3 ?-*/, 5)&1*-/2 BC ,./, />+2)&.*& 2'%= BC ?@

! B-/%)/2 8/'2,& 6Y 1+8/1,+-& J$-+%9 Z)%19 BLB 8/1,+-&KBrain insulin metabolism

o I/%1-*/& BC ?@ 8/1)2),/,*& &'(-/&()%/,'&! ?-*/, (/%1-*/& BC E),. +11)(', ,)2, $C?

Elevated homocysteine/C-Reactive proteino ?@ ,+ 2)5*- BC 8/1)2),/,*& &'(-/&()%/,'&

! B7&,*)%* 8/1)2),/,*& &'(-/&()%/,'& R+3+17&,*)%* 1/'&*& =2+>/2 )%.)>),)+%

o ?-*/, 2)5*- BC E),. -'> +- +11)(', ,)2, $C? /& )%0)1/,*0

Extra Thalamic Cortical Modulating System

o ['2,)(2* .*/0 (+)%, ?@ 8/1)2),/,*& '%)2/,*-/2 &'(-/&()%/,'&! S7* 2/,*-/2)P/,)+% &)0* ,+ &)0* &*5*-/2 ,)3*& 0)&-'(,& =/),

?@ ,+ / &)%=2* &*, +8 .*/0 (+)%,& E)22 %+-3/2)P* =/),o Q)&1*-/2 +- )33'%* BC ?@ %+-3/2)P*& =/), )%0)1/,*& )%82/33/,)+%9 )%&'2)%

07&-*='2/,)+%9 ,+7

,/(()%= ]^6_^ ,)3*&

Pyramidal pattern indicated by:

$(&)2/,*-/2 8)%=*- />0'1,+-&9 E-)&, *>)%= +- $C? ,+ )%5+25*0 BC

! L0-*%/2 BC ?@ )%0)1/,*& /0-*%/2 .+-3+%* )%5+25*3*%, B+--*1, >7 -'>>)%= +- $C? +8 )%5+25*0 BC

! I/%1-*/& BC ?@ )%0)1/,*& 07&=271*3)/ B+--*1, >7 -'>>)%= +- $C? +8 )%5+25*0 BC

! ?.7-+)0 BC ?@ )%0)1/,*& ,.7-+)0 )%5+25*3*%, B+--*1, >7 -'>>)%= +- $C? ,+ )%5+25*0 BC

o R*/0 (+)%, ?@ )%0)1/,*& %*'-+,-/%&3),,*- 07&8'%1,)+%


60/62

"_

ICAK International Conference 2013, Australia! B+--*1, >7 ,-*/,)%= )%5+25*0 .*/0 (+)%,

o $8 %+%* +8 ,.* />+5* ?@ 1.*1; 1+8/1,+-& 8+- BLB! B+--*1, E),. >-/)% $C?

Extremity subluxations

o ?*&, E),. &.+1; />&+->*- ,*1.%)A'*

Vestibulocerebellar loops

o I/,)*%, &,/%0)%= E),. *7*& 12+&*0! $% %*',-/2 (+&),)+% 1.*1; />)%= +- ()%1.)%= 0+ %+, %+-3/2)P* (*-8+-3 8)>)%= 3/&,+)0 (-+1*&&*& %+-3/2)P*& ,-*/, E),. $C?! $8 ()%1.)%= 3/&,+)0 (-+1*&&*& %+-3/2)P*& ,-*/, &*=3*%,/227! $8 -'>>)%= +- ()%1.)%= 0+ %+, %+-3/2)P* (*-8+-3 QHC 1/%1*2/,)+%

*>)%= +- ()%1.)%= 0+ %+, %+-3/2)P* (*-8+-3 QHC 1/%1*2/,)+%

*/1; /%0 8+-,. /%08+22+E 7+'- ,.'3> E),. 7+'- *7*& E.)2* ;**()%= .*/0 &,/,)+%/-7

B+3>)%* .*/0 /%0 ,/-=*, 3+5*3*%,9 E.)2* 3+5)%= 7+'- /-3 ,+ ,.* 2*8, 3+5* 7+'- .*/0 ,+ ,.* -)=.,9 =+ >/1;/%0 8+-,. E.)2* ;**()%= 7+'- *7*& +% 7+'- ,.'3>


61/62

]^

ICAK International Conference 2013, AustraliaVOR cancellation exercises:

B2/&( ./%0& E),. ,.'3>& '( /%0 *& -+,/,* /-3& /%0 .*/08-+3 ,.* 1*%,*- ,+ ,.* &)0* +8 ,.* (-*5)+'&27 )%.)>),*0 &'(-/&()%/,'& ,.*% >/1; ,+ ,.* 1*%,*-


62/62

ICAK International Conference 2013, AustraliaMetabolic Factors

Glutathione

B7&,*)%*9 X2',/3)1 L1)09 X271)%*o $8 ,E+ +8 ,.-** &,-*%=,.*%&O

! [/=%*&)'39 I+,/&&)'39 N6] $8 B7&,*)%* &,-*%=,.*%&O

o [/=%*&)'39 N6]9 V+2)1 /1)09 N6T`9 [*,.72 0+%+-! $8 B7&,*)%* &,-*%=,.*%& /%0 B7&,)%* E*/;*%&O

N6`9 M)/1)%/3)0*9 B+((*- $8 X2',/3)1 /1)0 &,-*%=,.*%&O

o N6]9 [/%=/%*&*9 N6"9 N6`9 N6b9 @)(+)1 /1)0 $8 X271)%* &,-*%=,.*%&O

o V+2)1 /1)09 [/%=/%*&*9 N6]9 N6`Bicarbonate Ion

Z)%19 N6]Ammonia weakens

N6]9 [+27>0*%'39 $-+%9 [/%=/%*&*9 N6"9 N)+,)%Clorox weakens

[/=%*&)'39 [*,.721+>+2/3)%9 N6]9 V+2)1 /1)09 c'*-1*,)%9 L%,)+0*%'39 FHd JB'9 [%9 Z%K

Documents

Richard Belli Workshop